Abstract
Molybdenum cofactor deficiency classically presents in neonates with intractable seizures; however, milder cases generally present before age 2 years with developmental delays and may go undiagnosed. Early diagnosis, and safe, US Food and Drug Administration-approved substrate replacement are critical to preserve neurologic function. This article discusses 2 children who presented with late-onset molybdenum cofactor deficiency type A.
| Originalsprog | Engelsk |
|---|---|
| Artikelnummer | e2023062548 |
| Tidsskrift | Pediatrics |
| Vol/bind | 153 |
| Udgave nummer | 6 |
| Antal sider | 7 |
| ISSN | 0031-4005 |
| DOI | |
| Status | Udgivet - 2024 |